ARGNF:OTCMKTS
argenx SE
US$ 790.15
0.00%
(0.00) Siku 1
13 Okt, 10:39:58 GMT -4 · USD
search
Alama zote
| Alama | Bei | Tofauti | Tofauti ya asilimia |
|---|
insights_autoInatayarisha maarifa maarufu ya ARGNF...
Mtaji wa soko
51.54B
Wastani wa kiasi cha mauzo
14.00
Kiasi cha mauzo ya hisa
0.00
Juu kwa wiki 52
US$ 1,020.00
Chini kwa wiki 52
US$ 708.72
Beta
0.46
Hisa za wawekezaji
62.89M
Idadi ya wafanyakazi
elfu 2
Mtaji wa soko
51.54B
Wastani wa kiasi cha mauzo
14.00
Kiasi cha mauzo ya hisa
0.00
Juu kwa wiki 52
US$ 1,020.00
Chini kwa wiki 52
US$ 708.72
Beta
0.46
Hisa za wawekezaji
62.89M
Idadi ya wafanyakazi
elfu 2
Habari
Kutoka kwenye vyanzo vya wavuti na washirika wa habari
ad-hoc-news.de
·
saa 5 zilizopita
Goldman lifts target for Argenx stock to EUR 959.00
Yahoo Finance
·
saa 7 zilizopita
Zacks Investment Ideas feature highlights: Cummins, Argenx and PACCAR
ad-hoc-news.de
·
saa 10 zilizopita
argenx sets October 22 results date as Argenx stock costs EUR 761.20
Investing.com South Africa
·
siku 1 iliyopita
Argenx shares may move 5.5% on earnings release next week By Investing.com
Wasifu
Argenx SE is a Belgian-Dutch pharmaceutical company specializing in immunology. Argenx specializes in the development of antibody therapies for the treatment of autoimmune diseases and cancer. Its work primarily focuses on the development of orphan drugs. Wikipedia
Kuhusu argenx SE
Afisa Mkuu Mtendaji (CEO)-
Wafanyakazielfu 1.86
Lilianzishwa25 Apr 2008
Makao makuu-
Sekta-
Tovutiargenx.com